Patents : |  |
| US Patent No. | Title |
| 7452727 | Method for increasing clinical specificity when detecting tumors and their precursor stages by simultaneously measuring at least two different molecular markers
|
| 7504225 | Reagents and methods for use in cancer diagnosis, classification and therapy
|
| 7510881 | Method and kit for the quantitative and/or qualitative detection of components in a sample
|
| 7517650 | Method of diagnosing breast cancer and compositions therefor
|
| 7521446 | Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
|
| 7524633 | Method of detection of prostate cancer
|
| 7525011 | Transgenic cancer models in fish
|
| 7538095 | Genetic inhibition by double-stranded RNA
|
| 7550300 | Prediction of bare metal stent restenosis
|
| 7553485 | Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof
|
| 7556920 | Gene BNO1 mapping to chromosome 16q24.3
|
| 7504103 | Methods of cancer diagnosis and therapy targeted against a cancer stem line
|
| 7502270 | Semiconductor memory device
|
| 7495082 | Antibodies to PRO4349 polypeptides
|
| 7459274 | Differential enzymatic fragmentation by whole genome amplification
|
| 7459531 | 50 Human secreted proteins
|
| 7459547 | Methods and compositions for controlling efficacy of RNA silencing
|
| 7462720 | Determination of nucleic acid using electrocatalytic intercalators
|
| 7465454 | Yeast-based vaccines as immunotherapy
|
| 7465786 | PRO1801 polypeptides
|
| 7470777 | Compositions and methods related to modified retroviral vectors for restricted, site specific integration
|
| 7479545 | PRO6001 antibodies
|
| 7494775 | Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer
|
| 7494783 | Method for assessing trait anxiety by determining cholinergic status
|
| 7556944 | Methods and compositions for use in preparing siRNAs
|
| 7557070 | Multiplexed cell analysis system
|
| 7595158 | Bcl2L12 polypeptide activators and inhibitors
|
| 7598028 | Compositions and methods for detecting and treating prostate disorders
|
| 7598031 | Method for the detection of gene transcripts in blood and uses thereof
|
| 7598052 | Expression profile of thyroid cancer
|
| 7601496 | Cleavage of nucleic acids
|
| 7601532 | Microarray for predicting the prognosis of neuroblastoma and method for predicting the prognosis of neuroblastoma
|
| 7608259 | Methods of cancer diagnosis and therapy targeted against a cancer stem line
|
| 7608449 | Methods and compositions related to high-titer pseudotyped retroviruses
|
| 7611840 | Method and device for the treatment of biological samples
|
| 7611847 | Method for identifying an intestinal phenotype
|
| 7588771 | Microorganisms for therapy
|
| 7588767 | Microorganisms for therapy
|
| 7585634 | Method of predicting risk of lung cancer recurrence, and a composition, kit and microarray for the same
|
| 7560253 | HLS-5 tumor suppressor factor
|
| 7560438 | Genetic inhibition by double-stranded RNA
|
| 7563447 | Yeast-based vaccines as immunotherapy
|
| 7563448 | Modified vaccinia ankara expressing P53 in cancer immunotherapy
|
| 7563572 | Method for long range allele-specific PCR
|
| 7563867 | PRO4356 polypeptides
|
| 7566774 | PRO4977 polypeptides
|
| 7569351 | P53 dependent apoptosis-associated gene and protein
|
| 7572633 | Use of the adenoviral E2 late promoter
|
| 7579154 | Annealing control primer and its uses
|
| 7612181 | Dual variable domain immunoglobulin and uses thereof
|
